12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

NGAL Test regulatory update

FDA accepted for review a 510(k) application from BioPorto for its NGAL Test to diagnose acute kidney...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >